This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Q&A with Dr Kevin Fernando: Appropriate treatment options for a person with T2DM on metformin requiring treatment intensification, with special focus on functional status and comorbidities

Length: 02:00

In this Q&A, Dr Kevin Fernando considers appropriate treatment options for a person with T2DM on metformin who requires treatment intensification, with special focus on functional status and comorbidities.

“One of my older patients with T2DM is currently taking metformin but requires treatment intensification. Her current HbA1c level is 9.1% (76 mmol/mol) and her target level is 8.0%
(64 mmol/mol). She has poor renal function (eGFR is 35 ml/min/1.73 m2) but has no history of cardiovascular disease. She is active with a good functional status. What is the most appropriate class of treatment for this patient?”

More information about diabetes:

Supporting documentation

JANUVIA® (sitagliptin) 100 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

JANUVIA® (sitagliptin) 50 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

JANUVIA® (sitagliptin) 25 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

GB-DIA-00239 | Date of Preparation: April 2019